Julie Park, Ph.D. - Publications
Affiliations: | Stanford University, Palo Alto, CA |
Year | Citation | Score | |||
---|---|---|---|---|---|
2007 | Akache B, Grimm D, Shen X, Fuess S, Yant SR, Glazer DS, Park J, Kay MA. A two-hybrid screen identifies cathepsins B and L as uncoating factors for adeno-associated virus 2 and 8. Molecular Therapy : the Journal of the American Society of Gene Therapy. 15: 330-9. PMID 17235311 DOI: 10.1038/Sj.Mt.6300053 | 0.546 | |||
2005 | Akache B, Glazer D, Park J, Kay MA. 1084. A Screen for Host Cellular Proteins That Interact with Adeno-Associated Virus Capsid Proteins Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.631 | 0.492 | |||
2005 | Park J, Yant SR, Kay MA. 191. Identification of a Novel Functional Domain in the Sleeping Beauty Transposase: Towards Alleviating the Restriction of SB Overproduction Inhibition Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.06.194 | 0.533 | |||
2004 | Yant SR, Park J, Huang Y, Mikkelsen JG, Kay MA. Mutational analysis of the N-terminal DNA-binding domain of sleeping beauty transposase: critical residues for DNA binding and hyperactivity in mammalian cells. Molecular and Cellular Biology. 24: 9239-47. PMID 15456893 DOI: 10.1128/Mcb.24.20.9239-9247.2004 | 0.511 | |||
2004 | Yant SR, Park J, Huang Y, Mikkelsen JG, Kay MA. 819. Hyperactive Transposase Mutants of the Sleeping Beauty Transposon Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.717 | 0.524 | |||
2004 | Park J, Yant SR, Kay MA. 148. The altered binding properties of sleeping beauty transposase hyperactive mutants may explain their enhanced efficacy Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.072 | 0.51 | |||
Show low-probability matches. |